04/11/2024
7:30 PM | Arcutis Biotherapeutics (Issuer)
Topper David Joseph (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/11/2024
7:32 PM | Arcutis Biotherapeutics (Issuer)
Topper David Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2024
3:15 PM | Arcutis Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/06/2024
4:12 PM | Arcutis Biotherapeutics (Issuer)
Burnett Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
4:14 PM | Arcutis Biotherapeutics (Issuer)
Matsuda Masaru (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
4:08 PM | Arcutis Biotherapeutics (Issuer)
Moore Matthew Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
4:09 PM | Arcutis Biotherapeutics (Issuer)
Watanabe Todd Franklin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
03/06/2024
11:40 AM | Arcutis Biotherapeutics (Subject)
Frazier Life Sciences VIII, L.P. (Filed by)
| Form SC 13D/A | |
03/06/2024
9:31 AM | Arcutis Biotherapeutics (Subject)
JENNISON ASSOCIATES LLC (Filed by)
| Form SC 13G/A | |
03/04/2024
4:44 PM | Arcutis Biotherapeutics (Subject)
OSBORNE DAVID W (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024
4:47 PM | Arcutis Biotherapeutics (Subject)
Watanabe Todd Franklin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024
4:38 PM | Arcutis Biotherapeutics (Subject)
Burnett Patrick (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024
4:40 PM | Arcutis Biotherapeutics (Subject)
Matsuda Masaru (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024
4:42 PM | Arcutis Biotherapeutics (Subject)
Moore Matthew Richard (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2024
3:21 PM | Arcutis Biotherapeutics (Filer)
| Form 424B5 | |
02/27/2024
3:34 PM | Arcutis Biotherapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/27/2024
6:48 AM | Arcutis Biotherapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/27/2024
6:44 AM | Arcutis Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/15/2024
5:36 PM | Arcutis Biotherapeutics (Issuer)
Burnett Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
5:47 PM | Arcutis Biotherapeutics (Issuer)
Moore Matthew Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
5:23 PM | Arcutis Biotherapeutics (Issuer)
Smither John W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
5:30 PM | Arcutis Biotherapeutics (Issuer)
Watanabe Todd Franklin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
5:32 PM | Arcutis Biotherapeutics (Issuer)
Matsuda Masaru (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
3:19 PM | Arcutis Biotherapeutics (Subject)
| Form SC TO-I/A | |
02/15/2024
3:20 PM | Arcutis Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/13/2024
11:29 AM | Arcutis Biotherapeutics (Subject)
SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by)
| Form SC 13G/A | |
02/13/2024
8:26 AM | Arcutis Biotherapeutics (Subject)
Polar Capital Holdings Plc (Filed by)
| Form SC 13G/A | |
02/12/2024
8:52 AM | Arcutis Biotherapeutics (Subject)
MORGAN STANLEY (Filed by)
| Form SC 13G | |
02/12/2024
5:06 AM | Arcutis Biotherapeutics (Subject)
Rubric Capital Management LP (Filed by)
| Form SC 13G | |
02/08/2024
11:15 PM | Arcutis Biotherapeutics (Filer)
| Form EFFECT | |
02/08/2024
11:52 AM | Arcutis Biotherapeutics (Subject)
JENNISON ASSOCIATES LLC (Filed by)
| Form SC 13G | |
01/31/2024
4:22 PM | Arcutis Biotherapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
01/29/2024
2:26 PM | Arcutis Biotherapeutics (Subject)
BlackRock Inc. (Filed by)
| Form SC 13G | |
01/23/2024
9:26 AM | Arcutis Biotherapeutics (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/17/2024
3:28 PM | Arcutis Biotherapeutics (Issuer)
Moore Matthew Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
3:30 PM | Arcutis Biotherapeutics (Issuer)
Watanabe Todd Franklin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
3:32 PM | Arcutis Biotherapeutics (Issuer)
Matsuda Masaru (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
3:34 PM | Arcutis Biotherapeutics (Issuer)
Edwards Larry Todd (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
3:35 PM | Arcutis Biotherapeutics (Issuer)
Burnett Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2024
5:03 AM | Arcutis Biotherapeutics (Subject)
| Form SC TO-I | |
01/03/2024
4:30 PM | Arcutis Biotherapeutics (Issuer)
Burnett Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
The #1 Biotech Stock to Have on Your Radar in 2024… (Ad) Revenues exploding, a $18.70 price target, and highly lucrative addressable markets make this one you cannot ignore! Learn more about why Zack’s has a BULLISH nearly $19 price target on BSEM right now! |
01/02/2024
1:29 PM | Arcutis Biotherapeutics (Subject)
Burnett Patrick (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/22/2023
4:24 PM | Arcutis Biotherapeutics (Issuer)
Watanabe Todd Franklin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/22/2023
2:26 PM | Arcutis Biotherapeutics (Subject)
Turney Patricia A. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/18/2023
5:33 AM | Arcutis Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/01/2023
7:51 PM | Arcutis Biotherapeutics (Issuer)
Watanabe Todd Franklin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/29/2023
2:51 PM | Arcutis Biotherapeutics (Subject)
Burrows Scott L (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/21/2023
4:47 PM | Arcutis Biotherapeutics (Issuer)
Matsuda Masaru (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2023
2:36 PM | Arcutis Biotherapeutics (Subject)
Matsuda Masaru (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/16/2023
12:13 PM | Arcutis Biotherapeutics (Subject)
Polar Capital Holdings Plc (Filed by)
| Form SC 13G | |
11/13/2023
8:02 AM | Arcutis Biotherapeutics (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
11/09/2023
1:54 PM | Arcutis Biotherapeutics (Subject)
PRUDENTIAL FINANCIAL INC (Filed by)
PRUDENTIAL FINANCIAL INC (Filed by)
| Form SC 13G | |
11/07/2023
2:33 PM | Arcutis Biotherapeutics (Subject)
BlackRock Inc. (Filed by)
| Form SC 13G/A | |
11/03/2023
6:32 AM | Arcutis Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/03/2023
6:36 AM | Arcutis Biotherapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/23/2023
3:23 PM | Arcutis Biotherapeutics (Filer)
| Form 424B5 | |
10/23/2023
3:25 PM | Arcutis Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/19/2023
3:02 PM | Arcutis Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/19/2023
3:15 PM | Arcutis Biotherapeutics (Filer)
| Form 424B5 | |
10/03/2023
8:45 PM | Arcutis Biotherapeutics (Issuer)
Edwards Larry Todd (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2023
8:41 PM | Arcutis Biotherapeutics (Issuer)
Edwards Larry Todd (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/27/2023
3:30 PM | Arcutis Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/15/2023
3:07 PM | Arcutis Biotherapeutics (Filer)
| Form 10-K/A | |
09/15/2023
3:08 PM | Arcutis Biotherapeutics (Filer)
| Form 10-Q/A | |
09/15/2023
3:09 PM | Arcutis Biotherapeutics (Filer)
| Form 10-Q/A | |
09/12/2023
6:39 AM | Arcutis Biotherapeutics (Issuer)
Moore Matthew Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/07/2023
5:48 AM | Arcutis Biotherapeutics (Filer)
| Form 8-K/A | |
09/05/2023
8:36 PM | Arcutis Biotherapeutics (Issuer)
Smither John W (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/05/2023
8:38 PM | Arcutis Biotherapeutics (Issuer)
Smither John W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2023
11:24 AM | Arcutis Biotherapeutics (Issuer)
Burnett Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/21/2023
9:58 AM | Arcutis Biotherapeutics (Subject)
Burnett Patrick (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/18/2023
3:32 PM | Arcutis Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/15/2023
3:31 PM | Arcutis Biotherapeutics (Subject)
Lock Kenneth A. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/14/2023
4:22 PM | Arcutis Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/02/2023
8:36 PM | Arcutis Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/02/2023
7:31 PM | Arcutis Biotherapeutics (Issuer)
Matsuda Masaru (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2023
6:16 PM | Arcutis Biotherapeutics (Issuer)
Heron Patrick J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2023
6:22 PM | Arcutis Biotherapeutics (Issuer)
LIN SUE-JEAN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2023
5:54 PM | Arcutis Biotherapeutics (Issuer)
Welgus Howard G. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2023
5:59 PM | Arcutis Biotherapeutics (Issuer)
Krishnamohan Neha (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2023
6:02 PM | Arcutis Biotherapeutics (Issuer)
Leonard Keith R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2023
6:08 PM | Arcutis Biotherapeutics (Issuer)
Gilbert Halley E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2023
6:10 PM | Arcutis Biotherapeutics (Issuer)
Curran Terrie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2023
6:13 PM | Arcutis Biotherapeutics (Issuer)
CHAUDHURI BHASKAR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2023
2:25 PM | Arcutis Biotherapeutics (Subject)
Matsuda Masaru (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/24/2023
4:03 PM | Arcutis Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
